|
Male, No. (%)
|
10 (40.0)
|
61 (40.9)
|
0.930
| | |
|
Age (m), Median (IQR)
|
3.6 (0.8–33.5)
|
3.0 (0.6–36.0)
|
0.909
| | |
|
Presence of any underlying disease, No. (%)
|
20 (80.0)
|
91 (61.1)
|
0.068
| | |
|
Premature and/or low birth weight, No. (%)
|
8 (32.0)
|
47 (31.5)
|
0.964
| | |
|
Tumor diseases, No. (%)
|
4 (16.0)
|
25 (16.8)
|
1.000
| | |
|
Aplastic anemia, No. (%)
|
1 (4.0)
|
2 (1.3)
|
0.909
| | |
|
Congenital heart disease, No. (%)
|
1 (4.0)
|
10 (6.7)
|
0.943
| | |
|
Lung disease, No. (%)
|
1 (4.0)
|
11 (7.4)
|
0.848
| | |
|
Digestive disease, No. (%)
|
5 (20.0)
|
10 (6.7)
|
0.071
| | |
|
Kidney diseas, No. (%)
|
1 (4.0)
|
3 (2.0)
|
1.000
| | |
|
Other disease, No. (%)
|
4 (16.0)
|
7 (4.7)
|
0.088
| | |
|
Nosocomial infection, No. (%)
|
5 (20.0)
|
51 (34.2)
|
0.156
| | |
|
Previous surgery and/ or trauma (within 3 months), No. (%)
|
8 (32.0)
|
16 (10.7)
|
0.011
|
0.006
|
7.006 (1.761–27.876)
|
|
Previous hospitalization (within 1 month), No. (%)
|
5 (20.0)
|
28 (18.8)
|
1.000
| | |
|
Previous antibiotic use (within 1 month), No. (%)
|
2 (8.0)
|
45 (30.2)
|
0.021
|
0.034
|
0.132 (0.020–0.860)
|
|
Likely source of infections
|
|
Lung infection, No. (%)
|
5 (20.0)
|
26 (17.4)
|
0.979
| | |
|
Abdominal infection, No. (%)
|
6 (24.0)
|
21 (14.1)
|
0.333
| | |
|
Urinary infection, No. (%)
|
1 (4.0)
|
25 (16.8)
|
0.175
| | |
|
Intracranial infection, No. (%)
|
0
|
2 (1.3)
|
1.000
| | |
|
Skin or soft tissue infection, No. (%)
|
0
|
20 (13.4)
|
0.082
| | |
|
Primary BSI, No. (%)
|
12 (48.0)
|
63 (42.3)
|
0.593
| | |
|
Laboratory findings
|
|
White blood cell count (*10^9),Median (IQR)
|
6.9 (3.5–11.3)
|
9.7 (5.3–13.9)
|
0.095
| | |
|
Neutrophil percentage, Median (IQR)
|
41.0 (9.5–63.1)
|
58.0 (34.8–72.7)
|
0.019
|
0.072
|
0.979 (0.957–1.002)
|
|
Hemoglobin (g/L), Median (IQR)
|
97.0 (72.5–138.0)
|
110 (95–147.5)
|
0.026
|
0.218
|
0.990 (0.973–1.006)
|
|
Platelet count ((*10^9), Median (IQR)
|
134 (41–227)
|
216 (117.5–352.0)
|
0.002
|
0.037
|
0.996 (0.991–1.000)
|
|
C-reactive protein (mg/dL), Median (IQR)
|
29 (6–132)
|
13 (3–80.5)
|
0.068
| | |
|
Elevated ALT, No. (%)
|
12 (48.0)
|
44 (29.5)
|
0.067
| | |
|
Elevated AST, No. (%)
|
15 (60.0)
|
75 (50.3)
|
0.371
| | |
|
MODS, No. (%)
|
7 (28.0)
|
8 (5.4)
|
0.001
|
0.752
|
1.288 (0.268–6.197)
|
|
Septic shock, No. (%)
|
4 (16.0)
|
9 (6.0)
|
0.180
| | |
|
Blood products transfusion, No. (%)
|
23 (92.0)
|
103 (69.1)
|
0.018
|
0.581
|
0.597 (0.096–3.720)
|
|
Indwelling catheter, No. (%)
|
19 (76.0)
|
96 (64.4)
|
0.258
| | |
|
Indwelling gastric tube, N(%)
|
14 (56.0)
|
61 (40.9)
|
0.159
| | |
|
Central venous catheter, N(%)
|
10 (40.0)
|
66 (44.3)
|
0.689
| | |
|
Urinary catheter, N(%)
|
2 (8.0)
|
5 (3.4)
|
0.587
| | |
|
Mechanical ventilation, N(%)
|
13 (52.0)
|
31 (20.8)
|
0.001
|
0.004
|
7.997 (1.906–33.546)
|
|
PICU admission, No. (%)
|
9 (36.0)
|
22 (14.8)
|
0.022
|
0.137
|
3.065 (0.701–13.408)
|
|
Inappropriate empirical treatment, No. (%)
|
9 (40.9)*
|
37 (25.3)*
|
0.127
| | |
